InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: None

Wednesday, 11/11/2015 12:37:51 AM

Wednesday, November 11, 2015 12:37:51 AM

Post# of 335
ZFGN's CC sounded encouraging to me plus the earnings seemed ok considering, although AH action was a little sleepy, loss of 73 cents per share beat wall street expectations of 80 cents.

Only two have dropped out of the trial and 55 remain, the FDA says Z311 will remain a pivotal study and apparently belonarib was not the cause of the patients death.

Zafgen's (ZFGN) CEO Tom Hughes on Q3 2015 Results - Earnings Call Transcript | Seeking Alpha
http://seekingalpha.com/article/3674356-zafgens-zfgn-ceo-tom-hughes-on-q3-2015-results-earnings-call-transcript?part=single
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LRMR News